What is Scintimun used for?

Scintimun is indicated for Nuclear medicine imaging procedure.

Scintimun is developed by CIS bio international.

What development phase is Scintimun in?

Scintimun is FDA-approved (marketed).

What is the generic name of Scintimun?

BESILESOMAB is the generic (nonproprietary) name of Scintimun.

Last reviewed 2026-04-20 · How we verify

Scintimun (BESILESOMAB)

CIS bio international · FDA-approved approved Monoclonal antibody Quality 13/100

At a glance

Generic name	BESILESOMAB
Sponsor	CIS bio international
Modality	Monoclonal antibody
Therapeutic area	Other
Phase	FDA-approved
First approval	2010

Approved indications

Nuclear medicine imaging procedure

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Scintimun CI brief — competitive landscape report
Scintimun updates RSS · CI watch RSS
CIS bio international portfolio CI